Cargando…

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas

INTRODUCTION: The prognostic significance of disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients has been demonstrated in many studies. Yet, it is not clear which of the primary tumors' biological factors predict hematogenous dissemination. We therefore examined '...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schindlbeck, Christian, Kampik, Theresa, Janni, Wolfgang, Rack, Brigitte, Jeschke, Udo, Krajewski, Stan, Sommer, Harald, Friese, Klaus
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410751/ https://www.ncbi.nlm.nih.gov/pubmed/16457698 http://dx.doi.org/10.1186/bcr1360

Ejemplares similares

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment
por: Vilsmaier, Theresa, et al.
Publicado: (2016)

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
por: Jäger, Bernadette A.S., et al.
Publicado: (2015)

Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer—Evaluation of Several Markers with Real-Time Reverse Transcription-PCR
por: Andergassen, Ulrich, et al.
Publicado: (2013)

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020)

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
por: Rack, Brigitte, et al.
Publicado: (2014)

Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011)

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
por: Roth, Carina, et al.
Publicado: (2010)

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
por: Stückrath, Isabel, et al.
Publicado: (2015)

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients
por: Zhang, Xi, et al.
Publicado: (2017)

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
por: Scholz, Christoph, et al.
Publicado: (2012)

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
por: Roth, Carina, et al.
Publicado: (2011)

Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
por: Heitmeir, Benedikt, et al.
Publicado: (2022)

Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study
por: Hauner, Dagmar, et al.
Publicado: (2020)

Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR
por: Andergassen, Ulrich, et al.
Publicado: (2013)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
por: Heublein, Sabine, et al.
Publicado: (2013)

Methylation patterns in serum DNA for early identification of disseminated breast cancer
por: Widschwendter, Martin, et al.
Publicado: (2017)

265. Rocky Mountain Spotted Fever Encephalopathy
por: Isaac, Sangeetha, et al.
Publicado: (2021)

Successful Removal of 265 Cm. of Gangrenous Intestine
por: Park, Roswell
Publicado: (1903)

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
por: Lenhard, Miriam, et al.
Publicado: (2012)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells
por: Trapp, Elisabeth Katharina, et al.
Publicado: (2017)

Disseminated Tumor Cells in Bone Marrow of Gastric Cancer Patients: Correlation with Tumor Hypoxia and Clinical Relevance
por: Bubnovskaya, Larissa, et al.
Publicado: (2014)

265 Wait at Least 60 Minutes After Eating
por: Gandhi, Stella, et al.
Publicado: (2012)

265. Common Organisms of Parotid abscess in Cambodian Children
por: Farrilend, Prak
Publicado: (2023)

Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
por: Shuai, Wen, et al.
Publicado: (2020)

Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange – Retrospective Analysis of 265 Cases
por: Lubnow, Matthias, et al.
Publicado: (2014)

Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer
por: Köpke, Melitta B., et al.
Publicado: (2022)

Glycosyltransferases as Markers for Early Tumorigenesis
por: Andergassen, Ulrich, et al.
Publicado: (2015)

P265 Phaeohyphomycosis caused by Rhinocladiella similis mimicking Sporotrichosis
por: Taneja, Juhi, et al.
Publicado: (2022)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients
por: Riethdorf, Sabine, et al.
Publicado: (2009)

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

Changes in Memory, Sedation, and Receptor Kinetics Imparted by the β2-N265M and β3-N265M GABA(A) Receptor Point Mutations
por: Abdulzahir, Alifayaz, et al.
Publicado: (2023)

Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Müller, Volkmar, et al.
Publicado: (2011)

A study of the working diamond between 26.5 and 27.0
por: Lauckner, R, et al.
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_eunombfnbk819l18ri9kai54vs